{"transactions":[{"id":1698742,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95779,"kind":"person","name":"Banard Charlene A.","position":1,"cik":"0001919506","reported_name":"Banard Charlene A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:28:13.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger, this option was exchanged for an option covering 2,662 shares of Cyclo Common Stock."}],"balance_after":0,"derivative":{"exercise_price":0.34,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-059927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059927/doc4.xml","form_type":"4"}},{"id":1698741,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95779,"kind":"person","name":"Banard Charlene A.","position":1,"cik":"0001919506","reported_name":"Banard Charlene A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:28:13.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated as of September 21, 2023 (the \"Merger Agreement\"), by and among Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc. and the Issuer, at the effective time of the Merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing."}],"balance_after":0,"derivative":{"exercise_price":3.13,"expiration_date":"2032-05-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-059927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059927/doc4.xml","form_type":"4"}},{"id":1698740,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95779,"kind":"person","name":"Banard Charlene A.","position":1,"cik":"0001919506","reported_name":"Banard Charlene A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:28:13.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated as of September 21, 2023 (the \"Merger Agreement\"), by and among Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc. and the Issuer, at the effective time of the Merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing."}],"balance_after":0,"derivative":{"exercise_price":7.52,"expiration_date":"2032-03-31","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-23-059927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059927/doc4.xml","form_type":"4"}},{"id":1854516,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95779,"kind":"person","name":"Banard Charlene A.","position":1,"cik":"0001919506","reported_name":"Banard Charlene A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T17:22:50.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the stock option granted on June 14, 2023 will become vested on the earlier of (i) June 14, 2024 or (ii) the business day prior to the date of the 2024 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":0.34,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-037440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123037440/doc4.xml","form_type":"4"}},{"id":1886448,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":95779,"kind":"person","name":"Banard Charlene A.","position":1,"cik":"0001919506","reported_name":"Banard Charlene A.","relationship":{"officer":true,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2023-05-19T00:17:21.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":19040,"price":2.037,"value":38784.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 and May 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee."}],"balance_after":276010,"source":{"system":"sec-edgar","filing":"0001140361-23-025561","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036123025561/form4.xml","form_type":"4"}},{"id":1971601,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":95779,"kind":"person","name":"Banard Charlene A.","position":1,"cik":"0001919506","reported_name":"Banard Charlene A.","relationship":{"officer":true,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-03T22:16:01.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":314325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/36th of the shares subject to the stock option vest and become exercisable each month, with the initial installment vesting on April 1, 2023, subject to the reporting person's continuous service."}],"balance_after":314325,"derivative":{"exercise_price":3.91,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":314325},"source":{"system":"sec-edgar","filing":"0001140361-23-010104","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036123010104/form4.xml","form_type":"4"}},{"id":1971600,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":95779,"kind":"person","name":"Banard Charlene A.","position":1,"cik":"0001919506","reported_name":"Banard Charlene A.","relationship":{"officer":true,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2023-03-03T22:16:01.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":139700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest in 12 equal quarterly installments on each Company Quarterly Vesting Date (as defined below), with the initial installment vesting on May 15, 2023, subject to the reporting person's continuous service. \"Company Quarterly Vesting Date\" means March 1, May 15, August 15 and November 15 of each year."}],"balance_after":295050,"source":{"system":"sec-edgar","filing":"0001140361-23-010104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036123010104/form4.xml","form_type":"4"}},{"id":2255377,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95779,"kind":"person","name":"Banard Charlene A.","position":1,"cik":"0001919506","reported_name":"Banard Charlene A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T17:16:00.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the stock option granted on May 24, 2022 will become vested on the earlier of (i) May 24, 2023 or (ii) the business day prior to the date of the 2023 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":3.13,"expiration_date":"2032-05-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-032257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122032257/doc4.xml","form_type":"4"}},{"id":2308549,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95779,"kind":"person","name":"Banard Charlene A.","position":1,"cik":"0001919506","reported_name":"Banard Charlene A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Right to Buy (Stock Option)","published_at":"2022-04-04T21:19:32.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option will become vested and exercisable on the Exercise Date set forth above and 1/36th of the shares subject to the option shall continue to vest each month thereafter, provided the Reporting Person is a service provider to the Issuer as of each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":7.52,"exercise_date":"2022-04-30","expiration_date":"2032-03-31","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-22-022749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122022749/doc4.xml","form_type":"4"}}]}